Grants Funded
Grant applicants for the 2024 cycle requested a total of nearly $3 million dollars. The PSF Study Section Subcommittees of Basic & Translational Research and Clinical Research evaluated more than 100 grant applications on the following topics:
The PSF awarded research grants totaling over $650,000 dollars to support more than 20 plastic surgery research proposals.
ASPS/PSF leadership is committed to continuing to provide high levels of investigator-initiated research support to ensure that plastic surgeons have the needed research resources to be pioneers and innovators in advancing the practice of medicine.
Research Abstracts
Search The PSF database to have easy access to full-text grant abstracts from past PSF-funded research projects 2003 to present. All abstracts are the work of the Principal Investigators and were retrieved from their PSF grant applications. Several different filters may be applied to locate abstracts specific to a particular focus area or PSF funding mechanism.
Degradable Orthopedic Devices to Modulate Healing
Samuel Lin MD
2013
Beth Israel Deaconess Medical Center
National Endowment for Plastic Surgery Grant
Cranio / Maxillofacial / Head and Neck
Degradable orthopedic plates and screws are available, but major clinical limitations exist which include osteolysis, sterile sinus formation, incomplete remodeling of the bone, and improper dynamics between device strength retention and wound healing. Furthermore, these screws are typically only used in pediatric patients due to lower intrinsic strength. We propose the use of degradable silk protein-based orthopedic devices (screws and plates) to overcome these limitations. The hypothesis is that silk-based screws and plates can provide osseous synthesis following fracture repair, fully degrade in a prescribed time frame, and proactively deliver therapeutic local agents to improve rates of integration, reduce infection and promote healing without requiring surgical removal. Based on extensive Preliminary Data, silk polymeric biomaterials provide mechanical properties to match conventional orthopedic fracture repair while also providing sustained release of therapeutic compounds and tunable degradation lifetimes. The outcome of the planned studies will be an entirely new and innovative set of orthopedic devices that provide: (a) a mechanical match to tissues during repair to avoid stress shielding, (b) full degradation over a six month time frame to allow regeneration by native tissue structure and function, (c) degradation to non inflammatory products – amino acids, and (c) release of antibiotics, anti-inflammatory and osteogenic factors to improve the rate of bone repair and improve surgical recovery. To address these outcomes, we will pursue three aims, materials optimization (Aim 1), in vitro assessment of function (Aim 2), and in vivo assessment of function (Aim 3). An interdisciplinary team of scientists and clinicians will address the needs. The team has assembled strong preliminary data to support the goals of the study.
